Overview
Ann Gramza is a Hematologist Oncology specialist and a Hematologist in Washington, Washington, D.c.. Dr. Gramza is rated as an Experienced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. Her top areas of expertise are Anaplastic Thyroid Cancer, Thyroid Cancer, Medullary Thyroid Carcinoma, and Laryngeal Cancer.
Her clinical research consists of co-authoring 8 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
University Of Maryland Oncology Associates PA
Ranee Mehra is an Oncologist and a Hematologist in Baltimore, Maryland. Dr. Mehra is rated as a Distinguished provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. Her top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Tongue Cancer, and Glossectomy. Dr. Mehra is currently accepting new patients.
Inova Health Care Services
John Deeken is an Oncologist and a Hematologist Oncology provider in Fairfax, Virginia. Dr. Deeken is rated as an Advanced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. His top areas of expertise are Laryngeal Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Throat Cancer, and Oral Squamous Cell Carcinoma. Dr. Deeken is currently accepting new patients.
Johns Hopkins University
Dr. Tanguy Seiwert is an oncologist in Baltimore, caring for patients with head and neck cancer. He serves as the director of the Head and Neck Cancer Oncology Disease Program and the co-director of the Bloomberg~Kimmel Institute for Immunotherapy at the Head and Neck Cancer Program at the Johns Hopkins School of Medicine. Dr. Seiwert earned his M.D. at Johannes Gutenberg Universität in Mainz, Germany. He completed his residency at the Duke University School of Medicine and performed a fellowship in hematology/oncology at the University of Chicago Medicine Mitchell Hospital-Hyde Park. Dr. Seiwert joined the Johns Hopkins faculty in 2019. Prior to joining Johns Hopkins, Dr. Seiwert was director of the Head and Neck Cancer Program at the University of Chicago. Dr. Seiwert’s research interests include immunologic and genomic profiling. He has given numerous invited talks on head and neck cancer both nationally and internationally. Dr. Seiwert served as chief editor for Frontiers in Head and Neck Cancer and as an editorial board member for the Journal of Clinical Oncology and Oral Oncology. He is a reviewer for multiple medical journals, including Lancet Oncology, Annals of Oncology and Clinical Cancer Research. He has been recognized by the American Association for Clinical Oncology for multiple Merit Awards and a Young Investigator Award. He was a member of the NCI Head and Neck Cancer Steering Committee, and is a member of the American Association for Clinical Oncology, the Society for Immunotherapy of Cancer, and the European Society of Clinical Oncology. Dr. Seiwert is rated as an Advanced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. His top areas of expertise are Glioma, Laryngeal Cancer, Tongue Cancer, Oral Squamous Cell Carcinoma, and Gastrostomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Anaplastic Thyroid CancerDr. Gramza isDistinguished. Learn about Anaplastic Thyroid Cancer.
- Laryngeal CancerDr. Gramza isDistinguished. Learn about Laryngeal Cancer.
- Medullary Thyroid CarcinomaDr. Gramza isDistinguished. Learn about Medullary Thyroid Carcinoma.
- Thyroid CancerDr. Gramza isDistinguished. Learn about Thyroid Cancer.
- Advanced
- Adenoid Cystic CarcinomaDr. Gramza isAdvanced. Learn about Adenoid Cystic Carcinoma.
- Follicular Thyroid CancerDr. Gramza isAdvanced. Learn about Follicular Thyroid Cancer.
- Papillary Thyroid CancerDr. Gramza isAdvanced. Learn about Papillary Thyroid Cancer.
- Polymorphous Low Grade Adenocarcinoma
- Throat CancerDr. Gramza isAdvanced. Learn about Throat Cancer.
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Adrenal CancerDr. Gramza isExperienced. Learn about Adrenal Cancer.
- Adrenocortical CarcinomaDr. Gramza isExperienced. Learn about Adrenocortical Carcinoma.
- Bone TumorDr. Gramza isExperienced. Learn about Bone Tumor.
- Epithelial-Myoepithelial CarcinomaDr. Gramza isExperienced. Learn about Epithelial-Myoepithelial Carcinoma.
- GliomaDr. Gramza isExperienced. Learn about Glioma.
